AnthroTronix has received U.S. FDA clearance for its computerized cognitive test battery known as DANA, which provides clinicians with objective measurements of reaction time to aid in the assessment of an individual’s medical or psychological state.

“In essence, measuring reaction time is like taking the temperature of the brain-like a ‘Brain Thermometer’-and it is a vital part of the data that a health professional needs to evaluate their patient,” said Corinna Lathan, founder and CEO of AnthroTronix.

Available for iOS and Android devices, DANA is indicated for use as part of any clinical assessment where concerns for changes in cognitive or psychological status are present. DANA’s battery of cognitive and psychological tests are administered and the results are evaluated by a qualified health professional who can assess factors that may affect measurement of reaction time such as concussion, dementia, post-traumatic stress, depression, stress, fatigue, prescription and non-prescription medications, and some nutritional supplements, among others.

DANA was initially developed through funding from the U.S. Navy Bureau of Medicine and Surgery and a Rapid Innovation Fund award by the U.S. Army to help evaluate the medical status of deployed military service members. The application has been tested in Afghanistan.

You can read the full 510(k) clearance of DANA from (note: PDF file).